Cancer causation: The Darwinian downside of past success?

Lancet Oncology

Volumn 3, Issue 4, 2002, Pages 244-251

  Greaves, Mel ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL TRANSFORMATION; DIET; ENVIRONMENT; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; EVOLUTION; EXPOSURE; FEMALE; GENE; GENE INTERACTION; GENETICS; HISTORY; HUMAN; MALE; MOLECULAR BIOLOGY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RISK; SKIN PIGMENTATION; SOCIAL ASPECT;

EID: 0036227338     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(02)00716-7     Document Type: Note

References (72)

1. The clonal evolution of tumor cell populations
2. The hallmarks of cancer
3. The causes of cancer
4. Cancer epidemiology in the last century and the next decade
5. Tobacco: The growing epidemic
6. Molecular epidemiology: On the path to prevention?
7. Cancer genetics
8. Epidemiological methods for studying genes and environmental factors in complex diseases
9. Mirage of health
10. Evolution and health: The new science of Darwinian medicine
11. Evolution and the origins of disease
12. Evolution in health and disease: Work in progress
13. Skin pigmentation regulaion of vitamin-D biosynthesis in man
14. The rise and fall of the third chmipanzee
15. Post-genome integrative biology: So that's what they call clinical science
16. Population attributable risk of breast cancer: Diet, nutrition, and physical exercise
17. Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats
18. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver
19. Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis" the "thrifty genotype" hypothesis enters the 21st century
20. Estimates of the world wide incidence of eighteen major cancers in 1985
21. Epidemiology of hormone-depending tumors
22. Global cancer statistics in the year 2000
23. Genistein: Does it prevent or promote breast cancer?
24. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progeseterone
25. Women's reproductive cancers in evolutionary context
26. Endogenous hormones as a major factor in human cancer
27. Epidemiology of breast cancer
28. Age at any birth is associated with breast cancer risk
29. Effects of breastfeeding on the mother
30. Biology of disease: Comparative study of human and at mammary tumorigenesis
31. Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy
32. Ramazzini and Rigoni-Stern on parity and breast cancer
33. Diseases of workers. Translated from the Latin text of 1713 by Wilmer Cave Wright
34. A short history of breast cancer
35. Smiliarities of prostate and breast cancer: Evolution, diet, and estrogens
36. Latent carcinoma of prostate at autopsy in seven areas
37. International trends and patterns of prostate cancer incidence and mortality
38. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols
39. Serum insulin-like growth factor-I levels and prostate cancer risk: Interpreting the evidence
40. Retrospective cohort mortality study of Roman Catholic priests
41. Sexual behaviour, STDs and risk for prostate cancer
42. Population genetics of BRCA1 and BRCA2
43. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
44. Observing the founder effect in human evolution
45. Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland
46. Cancer: Nature, nurture, or both
47. The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches
48. High constant incidence in twins and other relatives of women with breast cancer
49. A systematic review of genetic polymorphisms and breast cancer risk
50. Estrogen and the risk of breast cancer
51. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
52. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates
53. Increased risk of prostate cancer and benign prostatis hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect
54. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
55. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population
56. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanis men in Los Angeles, USA
57. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
58. Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk
59. BRCA1 mediates ligan-independent transcriptional repression of the estrogen receptor
60. Modification of BRCA1-and BRCA2-associated breast cancer risk by AIBI genotype and reproductive history
61. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
62. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration
63. Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids
64. Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics
65. Adaptation